The U.S. Patent and Trademark Office has issued a preliminary rejection of three key stem-cell patents owned by the University of Wisconsin-Madison, setting up a legal battle with potentially big economic and psychological ramifications for the state’s biotech economy.
The Wisconsin Alumni Research Foundation, the licensing arm of the university, vowed to appeal the ruling in every venue at its disposal, even if the dispute drags out in federal courts for years.